| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.23▼ | 1.21▼ | 1.21▼ | 1.31▼ | 1.29▼ |
| MA10 | 1.22▼ | 1.22▼ | 1.24▼ | 1.31▼ | 1.26▼ |
| MA20 | 1.25▼ | 1.27▼ | 1.29▼ | 1.32▼ | 1.07▲ |
| MA50 | 1.31▼ | 1.31▼ | 1.31▼ | 1.27▼ | 1.02▲ |
| MA100 | 1.32▼ | 1.31▼ | 1.31▼ | 1.08▲ | 1.11▲ |
| MA200 | 1.30▼ | 1.33▼ | 1.29▼ | 1.05▲ | 5.29▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.005▼ | -0.010▼ | -0.018▼ | 0.021▲ |
| RSI | 34.773▼ | 36.101▼ | 35.590▼ | 41.797▼ | 52.709▲ |
| STOCH | 47.381 | 29.762 | 11.854▼ | 51.141 | 44.850 |
| WILL %R | -85.714▼ | -92.593▼ | -92.857▼ | -95.652▼ | -60.575 |
| CCI | -65.051 | -68.067 | -80.998 | -198.094▼ | 35.675 |
|
Tuesday, July 29, 2025 04:58 AM
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma innovator, today announced its engagement with ICON Clinical Research Limited ("ICON") to expand it's Phase II Clinical Trial for ...
|
|
Wednesday, July 23, 2025 05:20 AM
July 23, 2025 — 08:20 am EDT Written by Quiver ForecastTracker for Quiver Quantitative -> ...
|
|
Tuesday, July 22, 2025 06:19 AM
NEW YORK, July 22, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma innovator, today announced a CRADA (Cooperative Research and Development Agreement) with ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/08/25 | 1.28 | 1.284 | 1.18 | 1.19 | 261,800 |
| 07/08/25 | 1.31 | 1.33 | 1.25 | 1.25 | 176,665 |
| 06/08/25 | 1.36 | 1.36 | 1.30 | 1.32 | 118,844 |
| 05/08/25 | 1.38 | 1.40 | 1.343 | 1.38 | 98,900 |
| 04/08/25 | 1.28 | 1.403 | 1.26 | 1.40 | 401,200 |
| 01/08/25 | 1.29 | 1.335 | 1.261 | 1.305 | 131,700 |
| 31/07/25 | 1.37 | 1.39 | 1.30 | 1.33 | 173,200 |
| 30/07/25 | 1.28 | 1.41 | 1.28 | 1.35 | 491,000 |
| 29/07/25 | 1.30 | 1.30 | 1.21 | 1.30 | 409,900 |
| 28/07/25 | 1.27 | 1.355 | 1.22 | 1.31 | 346,600 |
|
|
||||
|
|
||||
|
|